Surveillance for early stages of colon cancer: Potentials for optimizing follow-up protocols

World Journal of Surgical Oncology

Volumn 13, Issue 1, 2015, Pages

  Gilardoni, Elisa ^a   Bernasconi, Davide Paolo ^b   Poli, Silvia ^a   Garancini, Mattia ^a   Luperto, Margherita ^a   Zucchini, Nicola ^a   Bovo, Giorgio ^a   Totis, Mauro ^a   Bugatti, Alvaro ^a   Gianotti, Luca ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Colon cancer; Early stage; Follow up; Surgery; Surveillance

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; COLON CANCER; COLON RESECTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SURVEILLANCE; ECHOGRAPHY; ELECTIVE SURGERY; EMERGENCY SURGERY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROSPECTIVE STUDY; RECURRENCE RISK; RISK FACTOR; COLONIC NEOPLASMS; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; STANDARDS; SURVIVAL RATE; TUMOR INVASION; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84940198832     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/s12957-015-0674-7     Document Type: Article

References (39)

1. Gianotti L, Tamini N, Nespoli L, Rota M, Bolzonaro E, Frego R, et al. A prospective evaluation of short-term and long-term results from colonic stenting for palliation or as a bridge to elective operation versus immediate surgery for large-bowel obstruction. Surg Endosc. 2013;27:832-42.
2. Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN. Categorization for colon cancer based on national survival outcomes data. J Clin Oncol. 2010;28:264-71.
3. Vather R, Sammour T, Kahokehr A, Connolly AB, Hill AG. Lymph node evaluation and long-term survival in Stage II and Stage III colon cancer: a national study. Ann Surg Oncol. 2009;16(3):585-93.
4. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:979-94.
5. Merok MA, Ahlquist T, Røyrvik EC, Tufteland KF, Hektoen M, Sjo OH, et al. Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series. Ann Oncol. 2013;24:1274-82.
6. Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology. 2002;40:127-32.
7. Ueno H, Mochizuki H, Hashiguchi Y, Shimazaki H, Aida S, Hase K, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004;127:385-94.
8. Prall F, Nizze H, Barten M. Tumor budding as prognostic factor in stage I/II colorectal carcinoma. Histopathology. 2005;47:17-24.
9. Huijbers A, Tollenaar RA, vPelt GW, Zeestraten EC, Dutton S, McConkey CC, et al. The proportion of tumor stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol. 2013;24:179-85.
10. Mesker WE, Junggeburt JM, Szuhai K, de Heer P, Morreau H, Tanke HJ, et al. The carcinoma-stroma ratio of colon carcinoma is an independent fact of survival compared to lymph node status and tumor stage. Cell Oncol. 2007;29:387-98.
11. Törnqvist A, Ekelund G, Leandoer L. Early diagnosis of metachronous colorectal carcinoma. Aust NZJ Surg. 1981;51:442-5.
12. Heald RJ, Lockhart-Mummery HE. The lesion of the second cancer of the large bowel. Br J Surg. 1972;59:16-9.
13. Castells A, Bessa X, Daniels M, Ascaso C, Lacy AM, García-Valdecasas JC, et al. Value of postoperativen surveillance after radical surgery for colorectal cancer. Results of a cohort study. Dis Colon Rectum. 1998;41:714-24.
14. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow-up after curative resection for colorectal cancer: systematic review and meta-analysis of randomized trials. BMJ. 2002;324(7341):813.
15. Bruinvels D, Stiggelbout A, Kievit J, Van Houwelingen H, Habbema J, Van de Velde C. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg. 1994;219:174-82.
16. Jefferey M, Hickey B, Hider P. Follow-up strategies for patients treated for non metastatic colorectal cancer. Cochrane Database Syst Rev. 2007;1, CD002200.
17. Tjandra J, Chan M. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum. 2007;50:1783-99.
18. Scholefield JH, Steele RJ. Guidelines for follow up after resection of colorectal cancer. Gut. 2002;51 Suppl 5:V3-5.
19. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual. 7th ed. 2010. revised 2013.
20. Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26-32.
21. Buie WD, Attard JA. Follow up recommendations for colon cancer. Clin Colon Rectal Surg. 2005;18:232-43.
22. Hammod K, Margolin DA. The role of postoperative surveillance in colorectal cancer. Clin Colon Rectal Surg. 2007;20:249-54.
23. Hari DM, Leung AM, Lee JH, Sim MS, Vuong B, Chiu CG, et al. AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment? J Am Coll Surg. 2013;217:181-90.
24. Tsikitis VL, Malireddy K, Green EA, Christensen B, Whelan R, Hyder J, et al. Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial. J Clin Oncol. 2009;27:3671-6.
25. Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A. ESMO Guidelines Working Group. Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol. 2010;21 Suppl 5:v70-7.
26. Arnold CN, Goel A, Blum HE, Boland CR. Molecular pathogenesis of colorectal cancer. Cancer. 2005;104:2035-47.
27. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99:433-41.
28. Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10:65-71.
29. Wong JH, Severino R, Honnebier MB, Tom P, Namiki TS. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol. 1999;17:2896-900.
30. National Quality Forum. Specifications of the national voluntary consensus standards for breast and colon cancer. http://www.qualityforum.org/Publications/2009/05/National_Voluntary_Consensus_Standards_for_Quality_of_Cancer_Care.aspx . Accessed 18 Jan 2007.
31. Weiss JM, Pfau PR, O'Connor ES, King J, LoConte N, Kennedy G, et al. Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results-medicare data. J Clin Oncol. 2011;29:4401-9.
32. Dillman RO, Aaron K, Heinemann FS. McClure SEIdentification of 12 or more lymph nodes in resected colon cancer specimens as an indicator of quality performance. Cancer. 2009;115:1840-8.
33. Law CH, Wright FC, Rapanos T, Alzahrani M, Hanna SS, Khalifa M, et al. Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer. J Surg Oncol. 2003;84:120-6.
34. Xu CJ, Mikami T, Nakamura T, Tsuruta T, Nakada N, Yanagisawa N, et al. Tumor budding, myofibroblast proliferation, and fibrosis in obstructing colon carcinoma: the roles of Hsp47 and basic fibroblast growth factor. Pathol Res Pract. 2013;209:69-74.
35. Lai YH, Wu LC, Li PS, Wu WH, Yang SB, Xia P, et al. Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer. Colorectal Dis. 2014;16:259-64.
36. Ohtsuki K, Koyama F, Tamura T, Enomoto Y, Fujii H, Mukogawa T, et al. Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma. Anticancer Res. 2008;28:1831-6.
37. Kanazawa H, Mitomi H, Nishiyama Y, Kishimoto I, Fukui N, Nakamura T, et al. Tumor budding at invasive margins and outcome in colorectal cancer. Colorectal Dis. 2008;10:41-7.
38. Benson 3rd AB, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22:3408-19.
39. Gertler R, Rosenberg R, Schuster T, Friess H. Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy. Eur J Cancer. 2009;45:2992-9.